Zanamivir was the first of a new class of drugs called neuraminidase inhibitors. These drugs are a first line of defence against all strains of influenza virus. Once a new virus emerges it takes about six months to develop a vaccine, so neuraminidase inhibitors can slow the spread of infection and reduce morbidity and mortality in the early stages of an epidemic. They will be the only defence against an Asian Bird Flu pandemic when it strikes.
These drugs target an enzyme on the surface of the...
Copyright for the above image is held by MAAS and may be subject to third-party copyright restrictions. Please contact MAAS Rights and Permissions for information regarding reproduction, copyright and fees. Text is released under Attribution-Non Commercial-No Derivatives licenceSubmit an image license enquiry.
This object record is currently incomplete. Other information may exist in a non-digital form. The Museum continues to update and add new research to collection records.